Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines.
Nefrologia (Engl Ed)
; 41(4): 412-416, 2021.
Artigo
em Inglês
| MEDLINE | ID: covidwho-2105644
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide over the last year causing more than one million deaths. Several treatments have tried to modify the natural history of the coronavirus disease 2019 (COVID-19) but only corticosteroids have demonstrated to be effective in moderate or severe affectation. In that situation, the development of vaccines for preventing the SARS-CoV-2 infection has focused the attention of the scientific community. At present, available messenger RNA-based technology vaccines have received the approval of local and international sanitary authorities. In this position statement, the Spanish Society of Nephrology wants to state that patients with chronic kidney disease and healthcare workers are at high-risk for contagion and complications of COVID-19 so they must have priority in the vaccine administration.
Palavras-chave
Texto completo:
Disponível
Coleções:
Bases de dados internacionais
Base de dados:
MEDLINE
Assunto principal:
Vacinas
/
COVID-19
/
Nefrologia
Tipo de estudo:
Estudo prognóstico
Tópicos:
Vacinas
Limite:
Humanos
Idioma:
Inglês
Revista:
Nefrologia (Engl Ed)
Ano de publicação:
2021
Tipo de documento:
Artigo
País de afiliação:
J.nefroe.2021.09.001
Similares
MEDLINE
...
LILACS
LIS